Correction to: Response to Hydroxychloroquine in Japanese patients with Lupus-Related Skin Disease Using the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI)

Naoto YokogawaDepartment of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, JapanCorrespondence[email protected]

Akiko TanikawaDepartment of Dermatology, Keio University School of Medicine, Tokyo, Japan

Masayuki AmagaiDepartment of Dermatology, Keio University School of Medicine, Tokyo, Japan

Yukihiko KatoDepartment of Dermatology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan

Yoko MomoseDepartment of Dermatology, St. Luke’s International Hospital, Tokyo, Japan

Satoru AraiDepartment of Dermatology, St. Luke’s International Hospital, Tokyo, Japan

Hikaru EtoDepartment of Dermatology, St. Luke’s International Hospital, Tokyo, Japan

Takaharu IkedaDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan

Fukumi FurukawaDepartment of Dermatology, Wakayama Medical University, Wakayama, Japan

& the Japanese Hydroxychloroquine Study Group show all

"Correction to: Response to Hydroxychloroquine in Japanese patients with Lupus-Related Skin Disease Using the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI)." Modern Rheumatology, 24(4), p. 701

This article refers to:

Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Correction to: Response to Hydroxychloroquine in Japanese patients with Lupus-Related Skin Disease Using the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI)

Information for

Open access

Opportunities

Help and information

Correction to: Response to Hydroxychloroquine in Japanese patients with Lupus-Related Skin Disease Using the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature